---
title: "Phytomenadione - Postmenopausal Osteoporosis"
sidebar: mydoc_sidebar
permalink: db01022-mesh-d015663-1.html
toc: false 
---


Path ID: `DB01022_MESH_D015663_1`
{% include image.html url="images/db01022-mesh-d015663-1.png" file="db01022-mesh-d015663-1.png" alt="db01022-mesh-d015663-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D014812">MESH:D014812 </a> | Phytomenadione | Drug |
| <a href="https://identifiers.org/UniProt:P02818">UniProt:P02818 </a> | Osteocalcin | Protein |
| <a href="https://identifiers.org/GO:0030282">GO:0030282 </a> | Bone mineralization | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D015663">MESH:D015663 </a> | Postmenopausal osteoporosis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Phytomenadione | INCREASES ACTIVITY OF | Osteocalcin |
| Osteocalcin | POSITIVELY REGULATES | Bone Mineralization |
| Bone Mineralization | NEGATIVELY CORRELATED WITH | Postmenopausal Osteoporosis |
|---------|-----------|---------|

Comment: Phytomenadione promotes calcification of bones and can be supplemented together with calcium sources in cases of postmenopausal osteoporosis. Additionally phytomenadione may prevent arterial calcification in case of calcium supplementation [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566462/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566462/)

Reference: 
  - [https://go.drugbank.com/drugs/DB01022](https://go.drugbank.com/drugs/DB01022)
  - [https://pubmed.ncbi.nlm.nih.gov/3530901/](https://pubmed.ncbi.nlm.nih.gov/3530901/)
